NEW YORK (GenomeWeb) – Software is becoming an increasingly important part of Illumina's business, and will be a key focus of current President Francis deSouza when he takes the helm as CEO in July, current CEO Jay Flatley said in a Q&A at Goldman Sachs' Global Healthcare Conference last week, which was webcast.
Flatley, meantime, will stay on as executive chairman of Illumina and said that part of his role would involve tackling the reimbursement challenges for clinical next-generation sequencing products.